Alexandru Calin Grigorescu. “Tirosine Kinase Inhibitors (TKI) Used in the Treatment of Non-Small Cell Lung Cancer (NSCLC) Based on Specific Genetic Alterations”. Medical Science: Trends and Innovations Vol. 4, Feb. 2025, pp. 86-93, doi:10.9734/bpi/msti/v4/4098.